Den Bosch, Netherlands

Gerardus Antonius Schellekens

USPTO Granted Patents = 4 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2005-2014

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Gerardus Antonius Schellekens

Introduction

Gerardus Antonius Schellekens is a notable inventor based in Den Bosch, Netherlands. He has made significant contributions to the field of immunology, particularly in the development of peptides that are immunoreactive with autoantibodies in patients suffering from rheumatoid arthritis. With a total of four patents to his name, Schellekens has established himself as a key figure in medical research and innovation.

Latest Patents

One of Schellekens' latest patents focuses on peptides that are immunoreactive with autoantibodies from patients suffering from rheumatoid arthritis. This invention relates to a peptide derived from an antigen recognized by autoantibodies, which is reactive with autoimmune antibodies from patients with this condition. The peptide possesses a modified arginine residue, enhancing its effectiveness. Additionally, the invention includes antibodies against the peptide and a method for detecting autoimmune antibodies.

Career Highlights

Schellekens is associated with Stichting Voor De Technische Wetenschappen, where he continues to work on innovative solutions in the medical field. His research has been instrumental in advancing our understanding of autoimmune diseases and developing potential diagnostic tools.

Collaborations

Some of his notable coworkers include Waltherus Jacobus Wilhelmus Van Venrooij and Jozef Maria Hendrik Raats. Their collaborative efforts have contributed to the success of Schellekens' research and innovations.

Conclusion

Gerardus Antonius Schellekens is a distinguished inventor whose work has significantly impacted the field of immunology. His innovative patents and collaborations highlight his commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…